0001453814-18-000120.txt : 20180906
0001453814-18-000120.hdr.sgml : 20180906
20180906164547
ACCESSION NUMBER: 0001453814-18-000120
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180904
FILED AS OF DATE: 20180906
DATE AS OF CHANGE: 20180906
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bergmann Rouven
CENTRAL INDEX KEY: 0001641826
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34387
FILM NUMBER: 181058010
MAIL ADDRESS:
STREET 1: C/O MEDIDATA SOLUTIONS, INC.
STREET 2: 350 HUDSON STREET, 9TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10014
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Medidata Solutions, Inc.
CENTRAL INDEX KEY: 0001453814
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-PREPACKAGED SOFTWARE [7372]
IRS NUMBER: 522319066
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 350 HUDSON ST., 9TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10014
BUSINESS PHONE: 212.918.1800
MAIL ADDRESS:
STREET 1: 350 HUDSON ST., 9TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10014
4
1
wf-form4_153626673081688.xml
FORM 4
X0306
4
2018-09-04
0
0001453814
Medidata Solutions, Inc.
MDSO
0001641826
Bergmann Rouven
C/O MEDIDATA SOLUTIONS, INC.
350 HUDSON STREET, 9TH FLOOR
NEW YORK
NY
10014
0
1
0
0
Chief Financial Officer
Common Stock
2018-09-04
4
M
0
20000
53.29
A
98862
D
Common Stock
2018-09-04
4
S
0
20000
84.24
D
78862
D
Stock Option (right to buy)
53.29
2018-09-04
4
M
0
20000
0
A
2025-05-13
Common Stock
20000.0
37643
D
The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 26, 2018.
Such transaction was executed in multiple trades at prices ranging from $83.91 to $84.86. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
The options vested as to 25% of the shares on May 13, 2016 and 1/36th of the remaining options will become exercisable each month thereafter for the next 36 months.
/s/ Michael I. Otner, Attorney-in-Fact
2018-09-06